KNBIF (Kane Biotech) Total Operating Expense: $1.54 Mil (TTM As of Mar. 2026)


What is Kane Biotech Total Operating Expense?

Kane Biotech KNBIF +5.19% Total Operating Expense is $1.54 Mil as of Mar. 2026. The stock has 6 warning signs investors should review.

Kane Biotech's Total Operating Expense for the three months ended in Mar. 2026 was $0.49 Mil. Kane Biotech's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was $1.54 Mil.

Kane Biotech Total Operating Expense Related Terms

Kane Biotech Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Kane Biotech's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kane Biotech Total Operating Expense Chart

Kane Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.26 2.63 2.58 3.37 1.92

Kane Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.84 0.17 0.39 0.50 0.49

Kane Biotech Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.54 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $1.54 Mil mean?
Kane Biotech (KNBIF) has a Total Operating Expense of $1.54 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Kane Biotech and its competitors.
Is Kane Biotech's Total Operating Expense too high?
Kane Biotech's current Total Operating Expense is $1.54 Mil.
How does Kane Biotech's Total Operating Expense compare to VRTX and REGN?
Kane Biotech's Total Operating Expense of $1.54 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Kane Biotech and its competitors. Kane Biotech's current Total Operating Expense is $1.54 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kane Biotech stock overvalued right now?
Kane Biotech (KNBIF) has a current Total Operating Expense of $1.54 Mil. The current Total Operating Expense is $1.54 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Kane Biotech (KNBIF), the current Total Operating Expense is $1.54 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kane Biotech Business Description

Other Exchanges KNE:Canada
Address 290-100 Innovation Drive, Winnipeg, MB, CAN, R3T 6G2
Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise and acquired from research institutions. The company's operating segments are animal health and human health. It derives maximum revenue from Animal health segment.